2024-10-22 14:32:53
CStone announces the GEMSTONE-302 study of sugemalimab met the endpoint of overall survival in the first-line treatment of metastatic non-small cell lung cancer patients
Corporate/ 2023-07-24
CStone announces the GEMSTONE-302 study ...

Sugemalimab is the world\'s first PD-L1 monoclonal antibody that when administered along with chemotherapy improved overall survival of firs...

ImmVira's MVR-T3011 IV completed first 2 cohorts dose-escalation of U.S. Phase I clinical study with favorable safety data
Health/ 2023-07-22
ImmVira's MVR-T3011 IV completed fi...

SHENZHEN,China,Jan. 19,2022-- ImmVira\'s breakthrough product MVR-T3011 IV,global first clinical-stage oncolytic herpes simplex virus (oHSV)...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release